| 发明名称 |
Azaindazole compounds as CCRI receptor. |
| 摘要 |
Disclosed are compounds of the formula (I), useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Also disclosed are methods of making and methods of using same. |
| 申请公布号 |
AP201105685(D0) |
申请公布日期 |
2011.04.30 |
| 申请号 |
AP20110005685 |
申请日期 |
2009.09.22 |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
COOK BRIAN NICHOLAS;HARCKEN CHRISTIAN;DISALVO DARREN |
| 分类号 |
C07D471/04;A61K31/4375 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
